Clinical Trial

Sarcoidosis Immunotsuppressive Therapy and Lymphoma Development

Completed
View on ClinicalTrials.gov →
Summary
Impact of Immunosuppressive Therapy for Sarcoidosis on Lymphoma Development
Trial Details
NCT Number NCT07343401
Lead Sponsor Alexandria University
Conditions Sarcoidosis Lung
Enrollment 40 participants
Start Date 2025-08-01
Primary Completion 2025-12-30 (estimated)
Study Completion 2026-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-15